Skip to main content

Vandervoort Adam C's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Sep 3, 2025

Accession no.
0001477449-25-000107
Filed
Sep 3, 2025
Trade date
Aug 29-Sep 2, 2025
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $44.5K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vandervoort Adam CCIK 0001375088Officer (CHIEF LEGAL OFFICER, SECRETARY)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseAcquired+1,505––71,278Direct
Aug 29, 2025Common StockMOption exerciseAcquired+4,418––75,696Direct
Aug 29, 2025Common StockMOption exerciseAcquired+5,350––81,046Direct
Sep 2, 2025Common StockSSaleDisposed−5,867$7.59−$44,530.5375,179Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 29, 2025Common StockMOption exerciseDisposed−1,505$0.00$03,015Direct
Aug 29, 2025Common StockMOption exerciseDisposed−4,418$0.00$08,836Direct
Aug 29, 2025Common StockMOption exerciseDisposed−5,350$0.00$032,100Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)